KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesPension (IS)Profit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Colgate Palmolive (CL) EBT (2016 - 2025)

Colgate Palmolive has reported EBT over the past 17 years, most recently at $108.0 million for Q4 2025.

  • Quarterly results put EBT at $108.0 million for Q4 2025, down 89.12% from a year ago — trailing twelve months through Dec 2025 was $3.1 billion (down 22.65% YoY), and the annual figure for FY2025 was $3.1 billion, down 22.67%.
  • EBT for Q4 2025 was $108.0 million at Colgate Palmolive, down from $992.0 million in the prior quarter.
  • Over the last five years, EBT for CL hit a ceiling of $1.0 billion in Q2 2024 and a floor of $108.0 million in Q4 2025.
  • Median EBT over the past 5 years was $953.0 million (2021), compared with a mean of $807.8 million.
  • Biggest five-year swings in EBT: surged 648.48% in 2023 and later plummeted 89.12% in 2025.
  • Colgate Palmolive's EBT stood at $324.0 million in 2021, then tumbled by 59.26% to $132.0 million in 2022, then surged by 648.48% to $988.0 million in 2023, then rose by 0.51% to $993.0 million in 2024, then plummeted by 89.12% to $108.0 million in 2025.
  • The last three reported values for EBT were $108.0 million (Q4 2025), $992.0 million (Q3 2025), and $1.0 billion (Q2 2025) per Business Quant data.